Department of Eye and Vision Science, University of Liverpool, Liverpool, UK
Department of Glaucoma, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
BMJ Case Rep. 2021 Jul 9;14(7):e240504. doi: 10.1136/bcr-2020-240504.
Ozurdex is a dexamethasone intravitreal implant used for the treatment of macular oedema. A rare but serious complication is the migration of the implant into the anterior chamber (AC) in eyes with absent or incomplete posterior capsules that may lead to corneal decompensation. We report the case of a 75-year-old woman who presented with a 1-day history of decreased vision in her left eye. She had a history of complicated cataract surgery and had received multiple Ozurdex implants for postoperative cystoid macular oedema in the same eye. She had significant left corneal decompensation and a mobile Ozurdex implant in the AC. We report a simple but novel surgical technique for removing an Ozurdex implant from the AC using an intravenous cannula (Venflon). This technique can also be applied to removing a fluocinolone acetonide (Iluvien) implant in similar situations.
奥扎格雷是一种用于治疗黄斑水肿的地塞米松玻璃体内植入物。一种罕见但严重的并发症是,在没有或不完全的后囊的眼睛中,植入物迁移到前房(AC),可能导致角膜失代偿。我们报告了一例 75 岁女性患者,她左眼视力下降 1 天。她有复杂白内障手术史,并在同一只眼接受了多次奥扎格雷治疗术后囊下黄斑水肿。她的左眼有明显的角膜失代偿,AC 中有一个活动的奥扎格雷植入物。我们报告了一种简单但新颖的手术技术,使用静脉套管(Venflon)从 AC 中取出奥扎格雷植入物。这种技术也可以应用于在类似情况下取出氟轻松(Iluvien)植入物。